ArticleMedicine2026
Negative association of composite dietary antioxidant index and peripheral artery disease in US participants: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between the composite dietary antioxidant index (CDAI) and peripheral artery disease (PAD) remains inadequately explored. Elucidating this link is crucial for developing targeted nutritional strategies to mitigate PAD risk at both individual and public health levels. This analysis sought to evaluate the relationship between CDAI scores and the prevalence of PAD. We conducted a cross-sectional analysis utilizing data from the National Health and Nutrition Examination Survey (1999-2004). Participant demographics (age, sex, race, education, marital status, income-to-poverty ratio) and health-related factors (physical activity, body mass index, smoking status, total cholesterol, C-reactive protein, glycosylated hemoglobin, and histories of cardiovascular disease, hypertension, and diabetes) were collected. The association was examined using logistic regression, smoothed curve fitting, and interaction analyses. The study included 6018 individuals, with a PAD prevalence of 5.9% (n = 358). After comprehensive covariate adjustment, a significant inverse association between CDAI and PAD prevalence was observed (odds ratio [OR] = 0.96, 95% confidence interval [CI]: 0.92-1.00). When CDAI was analyzed as tertiles, participants in the middle tertile (T2) showed significantly lower odds of PAD compared to the lowest tertile (T1) (OR = 0.74; 95% CI = 0.56-0.98). The highest tertile (T3) also exhibited reduced odds, though not statistically significant (OR = 0.93; 95% CI = 0.69-1.24). Subgroup analyses consistently demonstrated this inverse trend, with no significant interaction effects detected (all P for interaction > .05). Our findings indicate that a higher CDAI is independently associated with a lower prevalence of PAD in United States adults. Future research is warranted to confirm these results and explore the underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.